
Bayer Partners with NextRNA to Develop Small Molecule Therapies for Cancer
Bayer and NextRNA Therapeutics, a biotechnology company dedicated to developing transformative medicines targeting long non-coding RNA (lncRNA)-driven diseases, have announced a collaboration and license agreement to develop small molecule therapeutics targeting lncRNAs in oncology. lncRNAs are a large class of…












